老年房颤患者口服抗凝药物的临床研究进展

Clinical research progress of oral anticoagulant drugs in elderly patients with atrial fibrillation

房颤发生血栓栓塞并发症是其致残、致死的主要原因。抗凝治疗是预防房颤卒中的有效措施。作者对老年房颤患者抗凝治疗的风险评估、药物选择、监测方法、用药指导以及不良反应的观察等研究进展作一综述,旨在为口服抗凝药物的老年患者提供安全有效的护理指导。

The complication of atrial fibrillation is the main cause of disability and death. Anticoagulant therapy is an effective measure to prevent stroke. This paper discuss the risk assessment of chiefly patients with atrial fibrillation antieoagulation, drug selection, monitoring methods, guidelines, adverse reactions of observation and related research progress in detail, which in order to provide the elderly patients with oral anticoagulant drugs with a safe and efective nursing instruction.